Dear Pharmacists,
On May 10th, the FDA expanded the emergency use authorization of the Pfizer vaccine to cover people aged 12 years and older. According to effectiveness data, there was a 100% effectiveness in the prevention of COVID-19 during the trial with adolescents. Safety data is still being reported for this trial population.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use